• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Authors



Ivan D. Meadows, MD

Latest:

Prevalence of Osteoporosis in Men in a VA Rehabilitation Center

Men in a VA rehabilitation unit who had osteoporosis were older and thinner, but otherwise similar (metabolic and functional status) to control subjects.


Sanjay Basu, MD, PhD

Latest:

Geographic Variations and Facility Determinants of Acute Care Utilization and Spending for ACSCs

Emergency department (ED) visits and hospitalizations for ambulatory care–sensitive conditions (ACSCs) among Medicaid patients constitute almost 40% of all ED visits and hospitalizations, with lower rates observed in areas with greater proximity to urgent care facilities and density of rural health clinics.



Pamela J. Kadlubek, MPH

Latest:

Advancing Performance Measurement in Oncology

The American Society of Clinical Oncology Quality Oncology Practice Initiative has grown to include 973 practices as of 2010. Practices demonstrated rates of end-of-life care and other measures of quality.



Steven R. Pliszka, MD

Latest:

Impact of Atypical Antipsychotic Use Among Adolescents With Attention-Deficit/Hyperactivity Disorder

A retrospective study of the treatment patterns and economic outcomes associated with off-label atypical antipsychotic use in the treatment of adolescents with attention-deficit/hyperactivity disorder.



Alan J. Forster, MD, MSc

Latest:

Automated Patient Assessments After Outpatient Surgery Using an Interactive Voice Response System

Using an interactive voice response system to contact patients after outpatient surgery will likely result in improved efficiency without a decrease in assessment quality.


Vanja Sikirica, PharmD, MPH

Latest:

Treatment Patterns Among Adults With ADHD Receiving Long-Acting Therapy

Adults with attention-deficit/hyperactivity disorder (ADHD) who received long-acting combination therapy had significantly lower adherence and persistence compared with those who received long-acting monotherapy.




Christine K. Norton, MA

Latest:

It Is Time to Ask Patients What Outcomes Are Important to Them

Patients with abdominal or back pain identified 21 outcomes important to them, but the reported outcomes are quite different from the symptom and function outcomes studied by researchers.


Vijay R. Nadipelli, MS, BPharm

Latest:

Heterogeneity of Nonadherent Buprenorphine Patients: Subgroup Characteristics and Outcomes

Patient and treatment heterogeneity were characterized within a sample of nonadherent buprenorphine members; an improved understanding of these factors may optimize patient—treatment matching and intervention efforts.




Peter Sauter, MBA

Latest:

Frequency of and Harm Associated With Primary Care Safety Incidents

Physicians' and nurses' assessments of the frequency and harm of incidents can be a supplemental method to study patient safety in the primary care office.



Thomas P. Harkins, MA, MPH

Latest:

Impact of Certified CME in Atrial Fibrillation on Administrative Claims

Use of administrative claims data is an innovative way of measuring the effect of continuing medical education on physician practice behavior and patient outcomes.


Michal Shani, MD

Latest:

Low Clinical Utility of Folate Determinations in Primary Care Setting

It seems that folate determinations in patients without known risk factors for folate deficiency are of little clinical significance.


Jennifer K. Maratt, MD

Latest:

Colorectal Cancer Screening in the 21st Century: Where Do We Go From Here?

Improving the appropriate use of colorectal cancer screening requires novel approaches to strike a balance between underuse and overuse.



Andrea Klemes, DO

Latest:

Payer Effects of Personalized Preventive Care for Patients With Diabetes

We examine the effects of MD–Value in Prevention (MDVIP) enrollment on Medicare expenditures and utilization among fee-for-service beneficiaries with diabetes over a 5-year period.


Richard G. Stefanacci, DO, MGH, MBA, AGSF, CMD

Latest:

The Curse of Being First: Lessons From Pharma’s Blockbuster Drugs

What can we learn from Biogen's decision to halt sales of aducanumab?



Karina L. Berenson, MPH

Latest:

Cost-Offset Analysis: Bimatoprost Versus Other Prostaglandin Analogues in Open-Angle Glaucoma

Treatment of glaucoma with bimatoprost is associated with cost savings compared with treatment with latanoprost or travoprost because of greater intraocular pressure reduction.


Harper Gordek, MPH

Latest:

Risk Adjustment in Home Health Care CAHPS

The authors disagree with previous research concluding that the Home Health Care Consumer Assessment of Healthcare Providers and Services (CAHPS) publicly reported data are insufficiently adjusted for patient comorbidities.



Anke-Peggy Holtorf, PhD, MBA

Latest:

Systematic Analysis of Outcomes Evaluations Applied to Drug Management Programs

Adopting quality measurement standards for drug management programs might increase the effectiveness and long-term sustainability of positive health outcomes for patients.


© 2024 MJH Life Sciences
AJMC®
All rights reserved.